Kesler Norman & Wride’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Buy
16,781
+17
+0.1% +$1.49K 0.24% 101
2026
Q1
$1.43M Buy
16,764
+65
+0.4% +$5.79K 0.25% 98
2025
Q4
$1.32M Buy
16,699
+1,041
+7% +$81.6K 0.23% 100
2025
Q3
$1.42M Sell
15,658
-290
-2% -$24.7K 0.28% 81
2025
Q2
$1.45M Sell
15,948
-695
-4% -$63.4K 0.26% 88
2025
Q1
$1.56M Buy
16,643
+985
+6% +$88.2K 0.3% 80
2024
Q4
$1.42M Sell
15,658
-203
-1% -$19.4K 0.31% 76
2024
Q3
$1.65M Sell
15,861
-3,498
-18% -$357K 0.32% 74
2024
Q2
$1.88M Sell
19,359
-2,225
-10% -$205K 0.4% 72
2024
Q1
$1.94M Sell
21,584
-1,166
-5% -$98.8K 0.41% 76
2023
Q4
$1.81M Buy
22,750
+157
+0.7% +$11.8K 0.42% 71
2023
Q3
$1.61M Sell
22,593
-593
-3% -$44.3K 0.4% 75
2023
Q2
$1.79M Buy
23,186
+333
+1% +$25.8K 0.43% 75
2023
Q1
$1.72M Buy
22,853
+1,166
+5% +$86.7K 0.43% 73
2022
Q4
$1.71M Buy
21,687
+8,291
+62% +$622K 0.44% 72
2022
Q3
$941K Sell
13,396
-31
-0.2% -$2.43K 0.26% 90
2022
Q2
$1.08M Buy
13,427
+159
+1% +$12.4K 0.3% 82
2022
Q1
$1.01M Buy
13,268
+27
+0.2% +$2.14K 0.22% 99
2021
Q4
$1.13M Buy
13,241
+176
+1% +$13.7K 0.24% 94
2021
Q3
$987K Sell
13,065
-16
-0.1% -$1.27K 0.23% 101
2021
Q2
$1.04M Sell
13,081
-3,942
-23% -$322K 0.24% 105
2021
Q1
$1.34M Buy
17,023
+1,130
+7% +$88.6K 0.33% 79
2020
Q4
$1.36M Buy
+15,893
New +$1.31M 0.38% 74

Other funds holding CL

Kesler Norman & Wride's CL Position: Q2 2026 in Review

Kesler Norman & Wride increased its Colgate-Palmolive (CL) stake by 0.1% in Q2 2026, buying an estimated $1.49K and bringing the position to 16,781 shares worth $1.54M. The position accounts for 0.24% of the portfolio, ranked #101.

Kesler Norman & Wride first reported a position in CL in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.94M in Q1 2024. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Kesler Norman & Wride held 16,781 shares of Colgate-Palmolive worth $1.54M as of Q2 2026.
  • Kesler Norman & Wride bought 17 Colgate-Palmolive shares in Q2 2026, an estimated $1.49K.
  • Colgate-Palmolive made up 0.24% of Kesler Norman & Wride's portfolio in Q2 2026, its #101 holding.
  • Kesler Norman & Wride first reported a position in Colgate-Palmolive in Q4 2020 and has held it in 23 quarters since.
  • Kesler Norman & Wride's Colgate-Palmolive position peaked at $1.94M in Q1 2024.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Kesler Norman & Wride's 13F filing for Q2 2026, filed 23 Jul 2026.